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Obesity-induced chronic inflammation is a key factor in type 2 diabetes. A vicious cycle
involving pro-inflammatory mediators between adipocytes and macrophages is a common
cause of chronic inflammation in the adipose tissue. Tomato is one of the most popular veg-
etables and is associated with a reduced risk of diabetes. However, the molecular mecha-
nism underlying the effect of tomato on diabetes is unclear. In this study, we focused on
anti-inflammatory compounds in tomato. We found that the extract of tomato reduced
plasma glucose and inflammatory markers in mice. We screened anti-inflammatory frac-
tions in tomato using lipopolysaccharide-stimulated RAW264.7 macrophages, and active
compounds were estimated by liquid chromatography-mass spectrometry over a wide
range. Surprisingly, a large number of compounds including oxylipin and coumarin deriva-
tives were estimated as anti-inflammatory compounds. Especially, 9-oxo-octadecadienoic
acid and daphnetin suppressed pro-inflammatory cytokines in RAW264.7 macrophages
inhibiting mitogen-activated protein kinase phosphorylation and inhibitor of kappa B α pro-
tein degradation. These findings suggest that tomato containing diverse anti-inflammatory
compounds ameliorates chronic inflammation in obese adipose tissue.
Introduction
Obesity is a major risk factor for the development of numerous complications, including type
2 diabetes and cardiovascular diseases[1,2]. Lifestyle-related diseases result from abnormal glu-
cose and lipid metabolism, which are primarily caused by obesity[2]. Obesity is an excessive
accumulation of adipose tissue that has become a worldwide concern. In recent years, several
studies have reported that obesity has been closely associated with low-grade chronic inflam-
mation in the adipose tissue[3,4–6]. The inflammation state of obesity increases infiltration of
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macrophages in the adipose tissue that are recruited by the monocyte chemoattractant protein
(MCP)-1 released from hypertrophied adipocytes[7–9]. These infiltrating macrophages cause
the secretion of various inflammatory cytokines such as nitric oxide (NO) and tumor necrosis
factor (TNF)-α, which can cause insulin resistance[10,11]. The interaction between adipocytes
and infiltrating macrophages in the adipose tissue contributes to the vicious cycle that leads to
chronic inflammation and glucose metabolism disorder under conditions of obesity[12,13].
Thus, in order to improve glucose metabolism, it is important to inhibit the production of
these inflammatory cytokines and suppress the low-grade inflammation in obese adipose
tissue.
Tomato is one of the most popular and commonly consumed fresh vegetables in the world.
Previous studies have indicated that the dietary intake of tomato is linked to a reduced risk of
chronic diseases such as cardiovascular diseases and type 2 diabetes[14–16]. Furthermore,
tomato consumption reduces inflammation by decreasing inflammatory cytokines in over-
weight and obese humans[17,18]. These interesting effects of tomato consumption have been
elucidated, but the active compounds in tomato are not fully understood. In recent years, we
demonstrated that tomato contained fatty acid derivatives (oxylipin) that activated lipid
metabolism via peroxisome proliferator-activated receptor (PPAR) α activation[19–21], which
is important for fatty acid oxidation[22–24]. Although the effect of compounds in tomato on
lipid metabolism has been elucidated, little is known about the effect on glucose metabolism.
The aim of this study was to identify anti-inflammatory compounds in tomato and to show
their mechanisms of action. In the present study, we demonstrated that tomato extract had the
ability to reduce plasma glucose level in mice. We focused on anti-inflammatory compounds
with the potential to reduce inflammatory cytokines associated with glucose metabolism disor-
der in obesity. To unravel the active compounds in tomato, we screened anti-inflammatory
fractions of tomato extract by measuring NO production in lipopolysaccharide (LPS)-stimu-
lated RAW264.7 macrophages. In addition, we attempted to identify active compounds from
the anti-inflammatory fractions using liquid chromatography-mass spectrometry (LC-MS).
This wide-range screening revealed that tomato contained a large number of anti-inflamma-
tory fractions and diverse anti-inflammatory compounds, including oxylipin and coumarin.
Representative compound of oxylipin and coumarin derivatives (9-oxo-ctadecadienoic acid
(9-oxo-ODA) and daphnetin (7,8-dihydroxycoumarin)) inhibited inflammatory cytokines by
suppressing mitogen-activated protein kinase (MAPK) phosphorylation and inhibitor kappa B
(IκB)-α protein degradation in RAW264.7 macrophages. Moreover, 9-oxo-ODA was detected
in vivo and tended to increase in the white adipose tissue (WAT) under tomato extract treat-
ment. These findings indicated that various anti-inflammatory compounds in tomato inhib-
ited chronic inflammation between adipocytes and macrophages in obese adipose tissue,
suggesting that tomato might be a valuable food to ameliorate glucose metabolism disorder
under conditions of obesity.
Materials and methods
Plant materials and chemicals
In this study, we used tomatoes that were provided by KAGOME CO., LTD. (Nasushiobara,
Tochigi, Japan) (identifier No. KTP001). All the other chemicals used were from Invitrogen
Corp. (Carlsbad, CA, USA), Nacalai Tesque Inc. (Kyoto, Japan), or Wako (Osaka, Japan) and
were guaranteed to be of reagent-, high-performance liquid chromatography (HPLC)-, or tis-
sue culture-grade.
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Animal experiments
Mice were kept in individual cages in a temperature-controlled room at 23 ± 1˚C and main-
tained under a constant 12 h light/dark cycle. Male C57BL/6 mice were purchased from CLEA
Japan (Tokyo, Japan). 7-week-old mice were maintained for 7 days on a normal diet (ND)
(Research Diet Inc., New Brunswick, NJ, USA) and then divided into two groups of similar
average body weight. Each group was maintained on a high-fat diet (HFD) containing 60%
kcal fat (Research Diet Inc.) or HFD containing 1% tomato extract (section 2.3) for 10 weeks.
This animal experiment was performed under free-feeding conditions. At the end of the treat-
ment period, anesthetized mice were sacrificed by cervical dislocation, and blood and organ
samples were collected. Plasma triglyceride (TG), glucose, and non-esterified fatty acid
(NEFA) levels were measured using the TG E-test Wako kit (Wako), Glucose CII-test (Wako),
and NEFA C-test (Wako), respectively. All animal experiments were approved by the Kyoto
University Animal Care Committee (approval code: 28–76).
Extract preparation and fractionation of crude extract
The extraction and fractionation of tomatoes were performed as follows. The components in
tomato were extracted from freeze-dried tomato powder using ethanol (EtOH) at room tem-
perature for 24 h. The EtOH extract was partitioned with ethyl acetate (EtOAc) (tomato
extract) and water mixture. The large-scale tomato extract for animal experiments was pre-
pared in TOKIWA Phytochemical Co., Ltd. (Chiba, Japan). On the guidance of NO assay (sec-
tion 2.7), the soluble portion of tomato extract was further partitioned with n-hexane (Hexane
extract) and 90% methanol (90% MeOH extract) mixture. Each soluble portion was fraction-
ated by silica gel open column chromatography (eluted with Hexane-EtOAc and MeOH, Hex-
ane: EtOAc = 100: 0 (I), 75: 25 (II), 50: 50 (III), 25: 75 (IV), 0: 100 (V), and 100% MeOH (VI)).
After silica gel open column chromatography, the Hexane and 90% MeOH extract (H-III,
M-II, III, and IV) was fractionated by reverse-phase HPLC on a 5C18-AR-II octa decyl silyl
(ODS) column (6.0×150 mm; Nacalai Tesque) using a mobile phase of water (solvent A) and
acetonitrile (solvent B) with 0.1% v/v formic acid added to both solvents. The Hexane extract
(H-V) was fractionated by reverse-phase HPLC on a 5C8-MS ODS column (6.0×150 mm;
Nacalai Tesque) using the same mobile phase. The program began with 1% solvent B in solvent
A followed by a linear elution gradient from 1 to 100% solvent B in solvent A for 130 min. To
monitor HPLC elution, a diode array detector was used in the range of 200–700 nm. Flow rate
was set at 1.0 mL/min. Eluted fractions were collected at 1 mL/min. The above-mentioned sol-
vents in extracts and eluted fractions were evaporated under vacuum at 37˚C using a rotary
evaporator. The effects of evaporated samples re-dissolved in EtOH on the production of the
pro-inflammatory mediators were examined.
mRNA expression levels
Total RNA was prepared using Sepasol (Nacalai Tesque) according to the manufacturer proto-
col. Using Moloney Murine Leukemia Virus (M-MLV) reverse transcriptase (Life Technolo-
gies Japan Ltd., Tokyo, Japan), total RNA was reverse transcribed, in accordance to the
manufacturer instructions using a thermal cycler (Takara PCR Thermal Cycler SP; Takara,
Shiga, Japan). To quantify mRNA expression levels, real-time quantitative polymerase chain
reaction (RT-PCR) analysis was performed with a LightCycler System (Roche Diagnostics,
Mannheim, Germany), using SYBR green fluorescence signals as described previously[25].
The oligonucleotide primer sets for mouse 36B4, β-Actin, Nos2, and Mcp-1 genes were
designed using a PCR primer selection program at the website of the Virtual Genomic Center
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from GenBank, and the sequences are shown in Table 1. All mRNA expression data are pre-
sented as ratios relative to the control in each experiment.
LC-MS analysis
The compounds of HPLC fractions and white adipose tissue were assessed using a LC-MS sys-
tem as previously described[21,25]. Briefly, each HPLC fraction was dissolved in 1mL of
extraction solvent (99.5% EtOH). Each white adipose tissue was homogenized in 1mL of
extraction solvent with mixer, and then the solvent was centrifuged. After centrifugation
(15,000 rpm, 10 min, 4˚C), the supernatant was collected for use as an extract. The extract was
filtered through a 0.2-μm-pore polyvinylidene difluoride (PVDF) membrane (Whatman,
Brentford, UK), and the filtrate was used for LC-MS. LC-MS was performed using a Waters
Acquity UPLC system (Milford, MA, USA) coupled to a Xevo QTOF-MS equipped with an
electrospray ionization source (ESI).
An aliquot of the extracted sample (3 μL) was injected into an Acquity UPLC BEH-C18
reversed-phase column (2.1×100 mm column size; 1.7 μm particle size). Mobile phases A
(water and 0.1% formic acid) and B (acetonitrile and 0.1% formic acid) were used. The column
temperature was set at 40˚C. The buffer gradient consisted of 30% to 50% B for 0–4 min, 50%
to 85% B for 4–14 min, 99% B for 14–17 min, and 30% B for 3 min at a flow rate of 300 μL/
min. The buffer gradient for daphnetin and esculetin analysis consisted of 1% B for 0–1 min,
1% to 50% B for 1–6 min, 50% to 99% B for 6–6.1 min, 99% B for 6.1–10 min, and 1% B for 5
min. Data were acquired with MassLynx software (Waters, Manchester, UK). External mass
calibration was performed following the manufacturer protocol.
Cell culture
Cell culture was performed as previously described[26]. Briefly, the RAW264.7 macrophage
was cultured in Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal bovine serum
(FBS) and 100 U/mL penicillin and 100 μg/mL streptomycin at 37˚C under a humidified 5%
CO2 atmosphere. To measure MCP-1, TNF-α, and NO levels, RAW264.7 cells were treated
with 100 ng/mL LPS and tomato extract, fraction, or authentic sample at various concentra-
tions in serum-free medium for 24 h. 3T3-L1 preadipocytes were subcultured in DMEM with
10% FBS supplemented with 100 U/mL penicillin and 100 μg/mL streptomycin at 37˚C under
a humidified 5% CO2 atmosphere. The differentiation of 3T3-L1 preadipocytes was induced
using adipogenic agents [0.5 mM 3-isobutyl-1-methylxanthine, 0.25 μM dexamethasone, and
10 μg/mL insulin] in DMEM containing 10% FBS for 2 days after the cells reached confluence
(day 0). Then, the medium was replaced with DMEM containing 10% FBS and 5 μg/mL insu-
lin, which was replaced with fresh medium every 2 days. Twenty days after the differentiation
induction, the cells that accumulated large lipid droplets were used as hypertrophied 3T3-L1
adipocytes.
Table 1. Oligonucleotide primers used for mRNA analysis.
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In the co-culture system, adipocytes and macrophages were co-cultured in a contact system
as previously described[12]. Briefly, RAW264.7 macrophages (1×105 cells/mL) were plated
onto dishes with serum-starved and hypertrophied 3T3-L1 cells, and the co-culture was incu-
bated in serum-free DMEM for 24 h. RAW264.7 and 3T3-L1 cells of equal numbers to those
in the co-culture were cultured separately as control cultures. 9-oxo-ODA, daphnetin, or
tomato extract was added to the co-culture at various concentrations as shown in each figure.
After 24 h of treatment, culture supernatants were collected, and inflammatory mediators
were measured as described below.
Measurement of inflammatory mediators
The concentrations of MCP-1 and TNF-α in the culture supernatants were determined by
enzyme-linked immunosorbent assay (ELISA) conducted using a Ready-SET-Go mouse
MCP-1 and TNF-α kit (eBioscience, San Diego, CA, USA) according to the manufacturer pro-
tocol. The amount of NO in the cell-free culture supernatants was measured using Griess
reagent[27]. Briefly, 100 μL of supernatant were mixed with an equivalent volume of Griess
reagent [1:1 (v/v) of 0.1% N-(1-naphthyl)-ethylenediamine in distilled water and 1% sulfanil-
amide in 5% phosphoric acid] in a 96-well flat-bottom plate. After 10 min, absorbance at 550
nm was measured, and the amount of NO was calculated from the sodium nitrite (NaNO2)
standard curve.
Western blotting
Proteins from RAW264.7 macrophages were solubilized in lysis buffer containing 20 mM Tris
HCl (pH 7.5), 15 mM NaCl, 1% Triton X100, and a protease and phosphatase inhibitor cock-
tail (Nacalai Tesque). The protein concentration of the cell lysate was determined using deter-
gent compatible (DC) protein assay (BioRad Laboratories, Hercules, CA, USA). Protein
samples were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE), and separated products were transferred to PVDF membrane (Millipore, Bed-
ford, MA, USA). After blocking with 5% skim milk in TBS and 0.1% Tween20, the membrane
was incubated with an anti-extracellular signal-regulated kinase (anti-ERK), anti-phosphory-
lated ERK (anti-pERK), anti-c-Jun N-terminal kinase (anti-JNK), anti-p38, anti-βactin (Cell
Signaling Technology, Beverly, MA, USA), or anti-IκB-α (Santa Cruz Biotechnology, Santa
Cruz, CA, USA) antibody overnight, and then with a secondary antibody conjugated to horse-
radish peroxidase (HRP) (Santa Cruz Biotechnology). The secondary antibody was visualized
using chemiluminescent HRP substrate (Millipore). For band quantification, ImageJ (National
Institutes of Health, Bethesda, MD, USA) was used.
Statistical analysis
The data are presented as means ± standard error of the mean (SEM). Data were assessed by
Student’s t-test or one-way ANOVA and Dunnett’s multiple comparison tests. Differences
were considered significant at p< 0.05.
Results
Effects of tomato extract on metabolism in vivo
First, we investigated the effect of tomato extract on metabolism in mice. No significant differ-
ences in body weight, tissue weight, and food intake between the HFD group and tomato
extract group were observed (Fig 1A and Table 2). Although plasma total NEFA levels did not
change (Fig 1D), plasma glucose and TG levels were reduced by tomato extract treatment (Fig
Wide-range screening of anti-inflammatory compounds in tomato using LC-MS
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1B and 1C). In the white adipose tissue, we observed that the mRNA expression of Nos2
involved in NO production was markedly decreased by tomato extract treatment (Fig 1E). Fur-
thermore, the expression of Mcp-1 tended to decrease under tomato extract treatment (Fig
1F). These results suggested that anti-inflammatory effect of tomato extract improved glucose
metabolism disorder in mice.
Screening of anti-inflammatory fraction by silica gel column
chromatography and HPLC in NO assay
To determine tomato extract (Fig 2A) has anti-inflammatory effect, we investigated whether
tomato extract inhibited NO production in LPS-stimulated RAW 264.7 macrophages. Tomato
extract significantly inhibited NO production in a dose-dependent manner (Fig 2B). To iden-
tify anti-inflammatory compounds in tomato extract, the extract was partitioned with n-hex-
ane and 90% MeOH mixture (Fig 2A), and the inhibitory effects of these portions (Hexane
Fig 1. Effect of tomato extract on metabolism in mice. (A) Body weight gain, plasma (B) glucose, (C) TG, and (D) NEFA levels in C57BL/6
mice. Effect of tomato extract on (E) Nos2 and (F) Mcp-1 mRNA expression levels in white adipose tissue. Data are presented as the
mean ± SEM (n = 8–10/group), p< 0.05 vs. HFD group. HFD; high fat diet, Tomato; tomato extract.
https://doi.org/10.1371/journal.pone.0191203.g001
Table 2. Effect of tomato extract on tissue weight in mice.
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Fig 2. Screening of partitioned fraction in NO assay. (A) Scheme of partitioning and open column chromatography of tomato extract. (B) NO
production by RAW264.7 cell stimulated with LPS (100 ng/mL) and incubated with tomato extract. (C) NO production by RAW264 cell stimulated
with LPS and incubated with partition fractions (Hexane, 90% MeOH extract) of tomato extract. NO production by RAW264.7 cell stimulated with
LPS and incubated with purified fractions of (D) Hexane or (E) 90% MeOH extract by open column chromatography. (F) Heat map of inhibitory
effect of NO production by RAW264.7 cell stimulated with LPS and incubated with HPLC fractions. Data are presented as means ± SEM (n = 3/
group). p< 0.05, p< 0.01 vs. LPS alone.
https://doi.org/10.1371/journal.pone.0191203.g002
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extract and 90% MeOH extract) on NO production by LPS-stimulated RAW264.7 macro-
phages were examined. The assay revealed that each portion inhibited NO production in a
dose-dependent manner (Fig 2C). Therefore, we further fractioned each portion by silica gel
open column chromatography (Fig 2A) and obtained five anti-inflammatory fractions (H-III,
H-V, M-II, M-III, and M-IV) (Fig 2D and 2E). To purify the active compounds in the five
anti-inflammatory fractions of open column chromatography, we separated the fractions by
reverse-phase HPLC and obtained 650 HPLC fractions (Fig 2F). NO assay was performed on
the 650 fractions acquired by HPLC. In consequence, a lot of anti-inflammatory fractions were
presented in HPLC fractions, including 9 fractions suppressed 80–100% of NO production, 21
fractions suppressed 60–80% of NO production, 27 fractions suppressed 40–60% of NO pro-
duction, 39 fractions suppressed 20–40% of NO production, and 89 fractions suppressed 10–
20% of NO production. Moreover, an overview of anti-inflammatory effect of tomato repre-
sented by the heat map indicated that 90% MeOH extract contained more potent anti-inflam-
matory fractions (Fig 2F).
Identification of anti-inflammatory compounds in HPLC fractions by
LC-MS
To identify the anti-inflammatory compounds in active HPLC fractions, we analyzed these
fractions by LC-MS. The results showed that a wide variety of active compounds were esti-
mated in HexaneIII (Table 3), HexaneV(Table 4), 90% MeOHII (Table 5), 90% MeOHIII
(Table 6), and 90% MeOHIV (Table 7)-HPLC fractions. Interestingly, we noticed that a num-
ber of lipid and coumarin analogs were present in these compounds (Tables 3–7). Therefore,
Table 3. LC-MS analysis data of Hexane III—HPLC fraction.







65 7.72 291.190 [M-H]- C18H28O3 13-oxo-OTA
65 7.82 291.190 [M-H]- C18H28O3 9-oxo-OTA
65 10.45 n.i.
70 8.99 293.211 [M-H]- C18H30O3 9-oxo-(EZ)-ODA
78 11.15 297.243 [M-H]- C18H34O3 Fatty acid derivative
82 12.13 277.213 [M-H]- C18H30O2 Linolenic acid
82 12.29 n.i.
82 13.64 279.231 [M-H]- C18H32O2 Linoleic acid
87 13.53 n.i.
87 13.67 279.231 [M-H]- C18H32O2 Linoleic acid
87 13.84 n.i.
93 14.95 255.230 [M-H]- C16H32O2 Palmitic acid
93 15.31 635.290 [M-H]- C31H40N8O7 ?
100 15.95 n.i.
n.d.; not ditected
n.i.; not identified parent ion
?; not annotated from database
https://doi.org/10.1371/journal.pone.0191203.t003
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we attempted to identify oxylipin and coumarin analogs in 90% MeOHII, III, and IV extracts
containing more potent anti-inflammatory fractions by LC-MS. Consequently, we identified 3
compounds of oxylipin (9-oxo-ODA (Fig 3A), 9-oxo-OTA (Fig 3B), and 13-HpOTrE
(Fig 3C)), and 5 compounds of coumarin derivatives (daphnetin (Fig 3D), esculetin (Fig 3D),
Table 4. LC-MS analysis data of Hexane V—HPLC fraction.




87 12.79 256.263 [M+H]+ C16H33NO Fatty amide
87 13.29 282.278 [M+H]+ C18H35NO Fatty amide
87 13.58 n.i.
93 14.97 255.230 [M-H]- C16H32O2 Palmitic acid
100 15.96 n.i.
114 16.08 n.i.
122 16.29 819.556 [M+H]+ C39H70N12O7 ?
n.d.; not ditected
n.i.; not identified parent ion
?; not annotated from database
https://doi.org/10.1371/journal.pone.0191203.t004
Table 5. LC-MS analysis data of 90%MeOH II—HPLC fraction.
HPLC Fraction NO. Rt (min) m/z Ion Form Estimated Molecule Formula Annotation
44 n.d.
52 n.d.




66 7.83 291.197 [M-H]- C18H28O3 9-oxo-OTA
66 8.13 n.i.
71 9.02 293.209 [M-H]- C18H30O3 9-oxo-(EZ)-ODA
71 9.32 293.209 [M-H]- C18H30O3 9-oxo-(EE)-ODA
73 9.46 364.286 [M-H]- C22H39NO3 ?
73 9.69 364.286 [M-H]- C22H39NO3 ?
73 9.74 293.212 [M-H]- C18H30O3 Oxylipin
73 9.98 364.286 [M-H]- C22H39NO3 ?
77 9.68 364.286 [M-H]- C22H39NO3 ?
82 12.16 277.216 [M-H]- C18H30O2 Linolenic acid
87 13.60 n.i.
87 13.64 279.230 [M-H]- C18H32O2 Linoleic acid
93 14.97 253.228 [M-H]- C16H32O2 Palmitic acid
99 15.88 277.142 [M-H]- C16H22O4 ?
n.d.; not ditected
n.i.; not identified parent ion
?; not annotated from database
https://doi.org/10.1371/journal.pone.0191203.t005
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4-hydroxycoumarin (Fig 3E), 4-methoxycoumarin (Fig 3F), and 7-hydroxy-4-methylcoumarin
(Fig 3G)). At first, the ion chromatogram peak of estimated molecule with the formula
C9H6O4 (annotated as daphnetin and esculetin, Table 7) in 90% MeOHIV F4 extract did not
separate, and we could not identify the compound relative to this fraction. Therefore, we
attempted to separate the peak in the 90% MeOH extract, and consequently both daphnetin
and esculetin were included (Fig 3D). Next, the inhibitory effects of these compounds (Fig 3I)
on NO production by LPS-stimulated RAW264.7 macrophages were examined. We showed
that 9-oxo-ODA and daphnetin significantly inhibited NO production (Fig 3H). Thus, we
Table 6. LC-MS analysis data of 90%MeOH III—HPLC fraction.
HPLC Fraction NO. Rt (min) m/z Ion Form Estimated Molecule Formula Annotation
11 n.d.
32 1.62 314.139 [M+H]+ C18H19NO4 ?
32 1.62 177.054 [M+H]+ C10H8O3 7-Hydroxy-4-methylcoumarin
32 1.70 163.036 [M+H]+ C9H6O3 4-Hydroxycoumarin
32 1.86 289.072 [M+H]+ C15H12O6 Eriodictyol
37 2.13 177.049 [M+H]+ C5H8N2O5 ?
37 2.44 273.073 [M+H]+ C15H12O5 Naringenin
37 2.57 177.049 [M+H]+ C10H8O3 4-Metoxycoumarin
44 3.58 181.0636 [M+H]+ C13H8O 9-Fluorenone
49 4.15 195.139 [M+H]+ C12H18O2 Fatty acid derivative
49 4.39 339.181 [M-H]- C18H28O6 Fatty acid derivative
49 5.67 230.249 [M+H]+ C14H31NO Xestoaminol C
52 4.75 355.248 [M-H]- C20H36O5 Fatty acid derivative
52 4.86 355.248 [M-H]- C20H36O5 Fatty acid derivative
54 5.11 357.262 [M-H]- C20H38O5 Fatty acid derivative
54 5.18 n.i.
54 5.45 329.233 [M-H]- C18H34O5 Oxylipin
54 5.45 445.150 [M-H]- C23H26O9 Flavonoid
61 6.66 311.222 [M-H]- C18H32O4 Oxylipin
61 6.82 357.262 [M-H]- C20H38O5 Fatty acid derivative
61 6.89 309.207 [M-H]- C18H30O4 Oxylipin
65 7.74 333.205 [M+H]+ C20H28O4 Fatty acid derivative
65 7.74 309.202 [M-H]- C18H30O4 13-HpOTrE
65 7.82 291.196 [M-H]- C18H28O3 9-oxo-OTA
70 9.02 293.208 [M-H]- C18H30O3 9-oxo-(EZ)-ODA
70 9.32 293.208 [M-H]- C18H30O3 9-oxo-(EE)-ODA
76 10.48 261.224 [M+H]+ C18H28O Fatty acid derivative
76 10.48 225.223 [M+H]+ C15H28O Fatty acid derivative
76 10.82 261.224 [M+H]+ C18H28O Fatty acid derivative
82 12.32 263.238 [M+H]+ C18H30O Isoprenoid
88 13.83 429.286 [M-H]- C23H42O7 ?
88 14.12 437.291 [M-H]- C25H42O6 Isoprenoid
93 15.00 253.232 [M-H]- C16H32O2 Palmitic acid
n.d.; not ditected
n.i.; not identified parent ion
?; not annotated from database
https://doi.org/10.1371/journal.pone.0191203.t006
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used 9-oxo-ODA and daphnetin on the behalf of lipid and coumarin derivatives derived from
tomato extract to elucidate the potential to suppress the production of pro-inflammatory
mediators.
Effects of tomato extract, 9-oxo-ODA and daphnetin on pro-inflammatory
cytokine production in LPS-stimulated macrophages
We demonstrated that tomato extract had the ability to decrease not only NO production (Fig
4A) but also TNF-α and MCP-1 production (Fig 4B and 4C) in a dose-dependent manner. We
investigated whether 9-oxo-ODA and daphnetin derived from tomato extract inhibited NO,
MCP-1, and TNF-α production in activated macrophages stimulated with LPS. Our data
showed that 9-oxo-ODA and daphnetin suppressed LPS-induced NO production in a dose-
dependent manner (Fig 4D). In addition, we observed that the mRNA expression of Nos2 was
decreased by 9-oxo-ODA treatment (S1 Fig). Furthermore, 9-oxo-ODA inhibited LPS-
induced TNF-α and MCP-1 production in a dose dependent manner (Fig 4E and 4F).
Although daphnetin inhibited LPS-induced TNF-α and MCP-1 production, its effect was
weaker than that of 9-oxo-ODA (Fig 4E and 4F). These results indicated that tomato extract,
9-oxo-ODA and daphnetin suppressed pro-inflammatory mediators in LPS-stimulated
macrophages.
Effects of tomato extract, 9-oxo-ODA and daphnetin on inflammation by
co-culture of adipocytes and macrophages
The vicious cycle that augments inflammation in obese adipose tissue was mimicked by the
co-culture of differentiated 3T3-L1 and RAW264.7 cells using a contact system. Indeed, the
co-culture of these cells exhibited a significant increase in NO, TNF-α, and MCP-1 production
Table 7. LC-MS analysis data of 90%MeOH IV—HPLC fraction.
HPLC Fraction NO. Rt (min) m/z Ion Form Estimated Molecule Formula Annotation
4 0.78 416.228 [M+H]+ C20H33NO8 ?
4 0.78 341.088 [M-H]- C15H18O9 Caffeic acid glucoside
4 0.78 175.024 [M-H]- C6H8O6 Ascorbate
4 0.97 177.042 [M-H]- C9H6O4 Daphnetin or Esculetin
64 7.28 200.202 [M+H]+ C12H25NO Fatty amide
64 7.46 265.148 [M-H]- C15H22O4 Terpenoid
64 7.62 n.i.
64 7.82 n.i.
81 11.49 658.4413 [M+H]+ C35H64NO8P Lysophospholipid
81 11.88 637.3062 [M-H]- C30H46N4O11 ?
81 12.23 n.i.
81 12.35 687.339 [M-H]- C37H52O12 ?
81 12.75 653.426 [M-H]- C36H62O10 ?
87 13.25 282.277 [M+H]+ C18H35NO Fatty amide
93 14.95 255.23 [M-H]- C16H32O2 Palmitic acid
99 15.85 n.i.
n.d.; not ditected
n.i.; not identified parent ion
?; not annotated from database
https://doi.org/10.1371/journal.pone.0191203.t007
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Fig 3. Identification of anti-inflammatory compounds. The extracted ion chromatogram of (A) 9-oxo-ODA (m/z = 293.209),
(B) 9-oxo-OTA (m/z = 291.196), (C) 13-HpOTrE (m/z = 309.20), (D) daphnetin and esculetin (m/z = 177.020), (E)
4-hydroxycoumarin (m/z = 163.036), (F) 4-methoxycoumarin (m/z = 177.049), and (G) 7-hydroxy-4-methylcoumarin (m/
z = 177.049). (H) Effect of identified compounds (50 μM) on NO secretion in RAW264.7 cell stimulated with LPS. Data are
presented as means ± SEM (n = 3/group). p< 0.05, p< 0.01 vs. LPS alone. (I) Structure of identified compounds. M; 90%
MeOH extract, H; hexane extract, F; HPLC fraction.
https://doi.org/10.1371/journal.pone.0191203.g003
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(Fig 5A–5F). We demonstrated that tomato extract decreased NO, TNF-α, and MCP-1 pro-
duction (Fig 5A–5C). 9-oxo-ODA and daphnetin treatment in the co-culture notably inhibited
NO production (Fig 5D). Although 9-oxo-ODA and daphnetin also suppressed NO produc-
tion, these compounds had no effect on TNF-α and MCP-1 production (Fig 5E and 5F). These
data indicated that 9-oxo-ODA and daphnetin derived from tomato extract mainly suppressed
NO production on inflammation by co-culture of adipocytes and macrophages.
Mechanism of inhibition of pro-inflammatory mediators by tomato
extract, 9-oxo-ODA and daphnetin
To clarify the mechanism of inhibition of pro-inflammatory cytokines by tomato extract,
9-oxo-ODA, and daphnetin, MAPKs (JNK, ERK, and p38) phosphorylation was examined in
LPS-stimulated RAW264.7 macrophages. The LPS treatment significantly facilitated the phos-
phorylation of MAPKs, whereas tomato extract inhibited this phosphorylation (Fig 6A). In
addition, LPS-induced IκB-α degradation, which leads to nuclear factor kappa B (NF-κB) acti-
vation, was suppressed by tomato extract (Fig 6A). The quantification of western blot signals
also showed that tomato extract inhibited the phosphorylation of MAPKs and IκB-α degrada-
tion in LPS-stimulated RAW264.7 macrophages (S2A–S2F Fig). 9-oxo-ODA inhibited JNK
Fig 4. Effects of tomato extract, 9-oxo-ODA, and daphnetin on secretion of inflammatory mediators by LPS-stimulated RAW264.7
macrophages. RAW264.7 cells were stimulated with LPS (100 ng/mL) and incubated with tomato extract, 9-oxo-ODA, or daphnetin for 24 h.
The levels of NO, TNF-α, and MCP-1 were measured. Effect of tomato extract on (A) NO, (B) TNF-α, and (C) MCP-1 secretion. Effect of
9-oxo-ODA and daphnetin on (D) NO, (E) TNF-α, and (F) MCP-1 secretion. Data are presented as means ± SEM (n = 3/group). p< 0.05,
p< 0.01 vs. culture treated with LPS alone. BAY; positive control for anti-inflammatory effect.
https://doi.org/10.1371/journal.pone.0191203.g004
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and p38 phosphorylation, and IκB-α degradation (Fig 6B), whereas daphnetin inhibited JNK,
ERK, and p38 phosphorylation, and IκB-α degradation (Fig 6B). These findings indicated that
the anti-inflammatory effects of tomato extract, 9-oxo-ODA and daphnetin were through sup-
pression of MAPKs phosphorylation and IκB-α degradation.
Discussion
In this study, we demonstrated for the first time that tomato extract possessed many types of
anti-inflammatory compounds (Fig 2F). We also showed that this extract was able to reduce
plasma glucose and TG level in HFD-fed mice (Fig 1B and 1C). Previous studies have indicated
that ingestion of tomatoes was related to suppression of various chronic diseases, including
type 2 diabetes, cancer, and cardiovascular diseases[14–16]. These interesting effects of tomato
are generally attributed to carotenoids, including lycopene[28,29]. It is well known that lyco-
pene has anti-oxidative[30] and anti-inflammatory properties[31]. On the other hand, we
showed that a large number of compounds in tomato, except carotenoids, have the ability to
Fig 5. Effects of tomato extract, 9-oxo-ODA, and daphnetin on inflammation induced by co-culture of 3T3-L1 adipocytes and
RAW264.7 macrophages. Differentiated 3T3-L1 adipocytes were co-cultured with RAW264.7 macrophages for 24 h. The levels of NO,
TNF-α, and MCP-1 in the co-culture medium were measured. Effect of tomato extract on (A) NO, (B) TNF-α, and (C) MCP-1 secretion.
Effect of 9-oxo-ODA and daphnetin on (D) NO, (E) TNF-α, and (F) MCP-1 secretion. Data are presented as means ± SEM (n = 3/group).
p< 0.05, p< 0.01 vs. non-treated co-culture. TNF-α in control (L1) and MCP-1 in control (RAW) are low limited of quantification.
BAY; positive control for anti-inflammatory effect.
https://doi.org/10.1371/journal.pone.0191203.g005
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Fig 6. Effects of tomato extract, 9-oxo-ODA, and daphnetin on JNK, ERK, and p38 phosphorylation, and IκB-α
degradation in RAW264.7 macrophages stimulated with LPS. RAW264.7 cells were stimulated with LPS (100 ng/
mL) and incubated with tomato extract, 9-oxo-ODA, or daphnetin for 1 h. Total cell lysates were extracted from
cultured RAW264.7 cells. Effect of (A) tomato extract, (B) 9-oxo-ODA, and daphnetin on phosphorylated JNK, ERK,
and p38, and IκB-α degradation. (C) Schematic illustration of the mechanism of inhibition of pro-inflammatory
mediators by tomato extract, 9-oxo-ODA, and daphnetin.
https://doi.org/10.1371/journal.pone.0191203.g006
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inhibit inflammation (Figs 2 and 3). LC-MS and database analysis showed that almost all the
compounds were specified as fatty acid and coumarin derivatives from HPLC fractions of the
90% MeOH extract (Tables 5–7 and Fig 2F). In addition, we demonstrated that 9-oxo-ODA
and daphnetin were identified as anti-inflammatory compounds from tomato extract (Fig 3).
Furthermore, 9-oxo-ODA, daphnetin and lycopene had an ability to reduce inflammation on
NO secretion (S3 Fig). Our results and previous findings raise the possibility that the effect of
tomato on inflammation is explained by factors other than carotenoids.
9-oxo-ODA is an oxylipin and an linoleic acid (LIA) derivative. There is a possibility that
enzymatic reaction participates in the production of 9-oxo-ODA[32]. It has been reported that
free fatty acids are the substrates for lipoxygenases (LOXs)[33] and that 9-LOX activity oxi-
dizes LIA at the C9 position to produce 9-hydroperoxy octadecatrienoic acid[34,35], which are
possible precursors of 9-oxo-ODA. In a previous study, we have reported that 9-oxo-ODA
activated PPARα[19]. It has been reported that PPARα promoted β-oxidation via enhance-
ment of its target gene expression[36–38]. This resulted in reduced fat storage[39,40]. There-
fore, PPARα is important for the regulation of lipid metabolism. In this study, we showed that
plasma TG level decreased by tomato extract treatment. Probably, 9-oxo-ODA was involved in
this process. On the other hand, we demonstrated for the first time that 9-oxo-ODA was not
only a PPARα activator but also showed anti-inflammatory properties. In addition, previous
studies have reported that PPARγ the subtype of PPARα, is likely to be concerned with anti-
inflammatory effect in LPS-stimulated macrophages[41,42]. Therefore, we investigated
whether the anti-inflammatory activities of 9-oxo-ODA participated in PPARα and PPARγ by
using antagonist with reference to the previous studies[19,42]. The anti-inflammatory activi-
ties of 9-oxo-ODA on NO production was unchanged by PPARα antagonist GW6471 and
PPARγ antagonist GW9662 (S4A and S4B Fig). Although our findings raise the possibility that
9-oxo-ODA is not related to PPARα and PPARγ on the inhibition of NO secretion, further
examination is necessary to elucidate the anti-inflammatory activities of 9-oxo-ODA via
PPARα and PPARγ. Our previous and present studies showed the functional diversity of
9-oxo-ODA and suggested that 9-oxo-ODA contributed to the effect of tomato on health
maintenance. In the tomato extract and white adipose tissue sample, we analyzed 9-oxo-ODA,
which had the strongest effect on NO secretion in LPS-stimulated RAW264.7 macrophages
(Fig 3H) using LC-MS. 9-oxo-ODA was detected in the tomato extract (Rt = 8.93 min, S1A
Fig). The amount of 9-oxo-ODA in the tomato extract was approximately 160 ng/mg (data not
shown). Furthermore, 9-oxo-ODA was also detected in the white adipose tissue and tended to
increase in presence of the tomato extract treatment (HFD group: approximately 35 ng/mg
WAT; Tomato extract group: approximately 60 ng/mg WAT; S1B Fig). We estimated that
9-oxo-ODA present at low level in HFD mice was an endogenous metabolite. The detection of
9-oxo-ODA in the white adipose tissue suggested that this compound acted directly as an anti-
inflammatory factor.
In this study, we demonstrated that daphnetin and esculetin were present in tomato extract
(Fig 3). Daphnetin, a natural coumarin derivative, is isolated from the traditional Chinese
medicinal herb Daphne odora var. marginata (D. marginata)[43]. In this work, although we
detected many types of coumarin (Table 6 and Fig 3), only two compounds (daphnetin and
esculetin) were able to inhibit inflammation (Fig 3H). It has been reported that these com-
pounds inhibit inflammation[44,45]. These compounds have two neighboring OH-groups
(Fig 3I). The neighboring OH-groups may be important for the anti-inflammatory effect. On
the other hand, 4-methoxycoumarin, 4-hydroxycoumarin, and 7-hydroxy-4-methylcoumarin,
which were identified from NO inhibitory fractions, had no effect on the suppression of NO
production (Fig 3H). ESI, a common method for metabolite analysis using LC-MS, was used
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for the identification of active compounds. We surmised that these fractions were likely to con-
tain other anti-inflammatory compounds, which were difficult to detect under ESI condition.
Previous studies have reported that chronic inflammation in the adipose tissue was impor-
tant for obesity[46] and that NF-κB[47] and MAPKs[48] were key factors of inflammation.
NF-κB is present in the cytoplasm in an inactive form owing to the binding to IκB-α[49]. IκB-
α degradation induces NF-κB translocation to the nucleus, resulting in the secretion of pro-
inflammatory factors[49]. Therefore, IκB-α degradation is involved in regulating obesity-
related inflammation[50,51]. MAPKs include three major groups: ERK, JNK, and p38 kinase
[48]. MAPKs induce activation of AP-1 transcription factor, which stimulates the expression
of inflammatory cytokine genes alone or in combination with NF-κB[48]. These findings sug-
gest that NF-κB and MAPKs are important for activation of obesity-related inflammation. In
this study, we demonstrated that tomato extract, 9-oxo-ODA and daphnetin had the ability to
inhibit IκB-α degradation and phosphorylation of MAPKs (Fig 6B and 6C).
In Fig 5, although tomato extract inhibited NO, TNF-α, and MCP-1 secretion, 9-oxo-ODA
and daphnetin had no effect on TNF-α and MCP-1 secretion. These findings suggested that
other compounds in tomato were likely to contribute to decrease TNF-α and MCP-1 secretion.
On the other hand, tomato extract, 9-oxo-ODA, and daphnetin inhibited NO secretion in the
co-culture (Fig 5). In a previous study, it has been reported that the suppression of NO secre-
tion contributes to improve glucose metabolism disorder[52]. We demonstrated that the
tomato extract decreased plasma glucose level and the expression of Nos2 involved in NO pro-
duction (Fig 1). Both our results and previous findings raise the possibility that tomato extract,
including 9-oxo-ODA and daphnetin, partly decreases plasma glucose level via suppression of
NO secretion.
Whereas we identified 9-oxo-ODA and daphnetin as anti-inflammatory compounds from
tomato extract, we also suggested that many other anti-inflammatory compounds remain to
be identified. Not only the effect of a few compounds alone but also the additive or synergistic
effect of many compounds should be taken into consideration when discussing more appro-
priate food function. In fact, many metabolites are contained in tomato fruit[53]. Therefore, in
this study we attempted to estimate many anti-inflammatory compounds by wide-range
screening using LC-MS. In consequence, we showed that a large number of anti-inflammatory
compounds may exist in tomato. Moreover, specified as fatty acid and coumarin derivatives
were identified as anti-inflammatory compounds. Even though this study provides novel
insights into the estimation of food function, further studies are necessary to elucidate the rela-
tionship between these compounds and the effect of tomato on inflammation. In conclusion,
wide-range screening using LC-MS and NO assay revealed that tomato possessed many anti-
inflammatory compounds. In particular, 9-oxo-ODA and daphnetin inhibited the secretion of
inflammatory cytokines via the suppression of NF-κB and MAPKs pathway. Furthermore, our
study suggested that the effect of tomato on suppression of plasma glucose and expression of
Nos2 in the white adipose tissue was partly caused by 9-oxo-ODA.
Supporting information
S1 Fig. Effect of 9-oxo-ODA and daphnetin on Nos2 mRNA expression levels by LPS-stim-
ulated RAW264.7 macrophage. RAW264.7 cells were stimulated with LPS (100 ng/mL) and
incubated with 9-oxo-ODA or daphnetin (50 μM) for 24 h. The levels of Nos2 mRNA expres-
sion were measured. Data are presented as means ± SEM (n = 4–6/group). p< 0.05 vs. culture
treated with LPS alone.
(PPTX)
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S2 Fig. The quantification of western blot signals on MAPKs phosphorylation and IκB-α
degradation in LPS-stimulated RAW264.7 macrophages treated with tomato extract.
RAW264.7 cells were stimulated with LPS (100 ng/mL) and incubated with tomato extract for
1h. Total cell lysates were extracted from cultured RAW264.7 cells. The quantification of west-
ern blot signals on (A) JNK1, (B) JNK2/3, (C) ERK1, (D) ERK2, (E) p38 phosphorylation, and
(F) IκB-α degradation. Data are presented as means ± SEM (n = 3–4/group). p< 0.05,
p< 0.01 vs. culture treated with LPS alone.
(PPTX)
S3 Fig. Effect of 9-oxo-ODA, daphnetin and lycopene on secretion of NO by LPS-stimu-
lated RAW264.7 macrophage. RAW264.7 cells were stimulated with LPS (100 ng/mL) and
incubated with 9-oxo-ODA, daphnetin and lycopene (30 μM) for 24 h. The levels of NO secre-
tion were measured. Data are presented as means ± SEM (n = 3/group). p< 0.05, p< 0.01
vs. culture treated with LPS alone.
(PPTX)
S4 Fig. Effect of 9-oxo-ODA on secretion of NO by LPS-stimulated RAW264.7 macro-
phage treated with or without PPARα, PPARγ antagonist. LPS-stimulated (100 ng/mL)
RAW264.7 cells were incubated with 9-oxo-ODA (30 μM) and treated with or without (A)
GW6471(10 μM), (B) GW9662 (10 μM) for 24h. GW6471 is a PPARα antagonist. GW9662 is
a PPARγ antagonist. Data are presented as means ± SEM (n = 3/group). n.s.; Not significant
vs. culture treated with LPS and 9-oxo-ODA.
(PPTX)
S5 Fig. LC-MS analysis of 9-oxo-ODA in tomato extract and white adipose tissue. (A) The
extracted ion chromatogram (m/z = 293.209) in tomato extract sample. (B) The amount of
9-oxo-ODA in white adipose tissue. Data are presented as means ± SEM (n = 8–10/group).
(PPTX)
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